SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
TELK -- Telik, Inc.
An SI Board Since October 2000
Posts SubjectMarks Bans Symbol
887 37 0 TELK
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
412TELK mentioned in Business week as a potential munchee: Message 19749129 Cheertuck-1/29/2004
411Don't know. He certainly has a track record for rolling a variety of commerscaram(o)uche-1/20/2004
410<i>Is Von Hoff one who was predicting bright future for MOGN Irofulven?<Biomaven-1/20/2004
409Is Von Hoff one who was predicting bright future for MOGN Irofulven? Or he contiMiljenko Zuanic-1/20/2004
408"MPC-6827 is certainly the best preclinical candidate that I have seen in sscaram(o)uche-1/20/2004
407Small potatos but Unlike KOSN... NEWMAN RICHARD B,DIRECTOR,BUYS 5,000 ON 12/08/0mopgcw-12/10/2003
406Cool. Thanks for finding that! (eom)scaram(o)uche-12/8/2003
405Celgene, Telik Drugs Ease Anemia in Bone-Marrow Study (Update1) 2003-12-08 16:41mopgcw-12/8/2003
404Quite a chunk. By any other name, a chunk.scaram(o)uche-12/5/2003
403TELK Completes $172.5M Stock Offering Telik, Inc. (TELK) announced that a totalmopgcw-12/4/2003
402Nadine Wong on Telik (buy target below $20, sell @$26) biospace.com Cheers, Ttuck-12/2/2003
401>>PALO ALTO, Calif. -(Dow Jones)- The Food and Drug Administration grantedtuck-12/2/2003
400Telik Announces Interim Results Showing Clinical Efficacy With TELCYTA(TM) In Conigel bates-11/20/2003
399Telik's TELINTRA(TM) Demonstrates Clinical Activity in Resistant Myelodysplascaram(o)uche-11/19/2003
398Telik's TELCYTA(TM) Demonstrates 63% Objective Response Rate in 2003-11-19 1mopgcw-11/19/2003
397>>PALO ALTO, Calif., Nov. 13 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaqtuck-11/13/2003
396From Briefing.com: >>9:10AM Telik started with an Outperform at CSFB; tartuck-11/7/2003
395Telik Announces Proposed Equity Offering Wednesday October 29, 5:07 pm ET PALOkeokalani'nui-10/29/2003
394Telik Announces Positive Interim Results From Phase 1-2a Clinical Trial Of TELCYnigel bates-10/21/2003
393Telik Announces Positive Interim Results From Phase 1-2a Trial Of TELCYTA(TM) (Tnigel bates-10/21/2003
392Telik Announces Positive Interim Results From Phase 1-2a Trial of TELCYTA(TM) (Tnigel bates-10/21/2003
391that is an interesting contrast to other's bravado.mopgcw-10/20/2003
390<i>I am never confident, Stefan. I am always worried, I always assume somenigel bates-10/20/2003
389Thanks for posting so many transcripts. You have given us a lot to digest.D.Lu-10/19/2003
388Joel Sendek, Lazard Freres & Co. LLC - Analyst [8] ----------------------mopgcw-10/19/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News